Bolt Biotherapeutics, Inc.

BOLTNasdaq· Pharmaceutical Preparations

Price History

Revenue

$7.7M

▲ 0.1% YoY

Net Income

-$33.4M

▲ 47.1% YoY

EPS

$-17.85

▲ 46.0% YoY

Cash

$11.7M

▲ 62.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.